Copyright Reports & Markets. All rights reserved.

Global Monoclonal Antibodies Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Monoclonal Antibodies Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Monoclonal Antibodies Market Size Growth Rate by Type
    • 1.4.2 Cancer
    • 1.4.3 Autoimmune Diseases
    • 1.4.4 Infection
    • 1.4.5 Hematological Diseases
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Monoclonal Antibodies Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Autoimmune and inflammatory diseases
    • 1.5.4 Respiratory diseases
    • 1.5.5 Ophthalmology
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Monoclonal Antibodies Market Size, Estimates and Forecasts
    • 2.1.1 Global Monoclonal Antibodies Revenue 2015-2026
    • 2.1.2 Global Monoclonal Antibodies Sales 2015-2026
  • 2.2 Global Monoclonal Antibodies, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Monoclonal Antibodies Competitor Landscape by Players

  • 3.1 Monoclonal Antibodies Sales by Manufacturers
    • 3.1.1 Monoclonal Antibodies Sales by Manufacturers (2015-2020)
    • 3.1.2 Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Monoclonal Antibodies Revenue by Manufacturers
    • 3.2.1 Monoclonal Antibodies Revenue by Manufacturers (2015-2020)
    • 3.2.2 Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2019
    • 3.2.5 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Monoclonal Antibodies Price by Manufacturers
  • 3.4 Monoclonal Antibodies Manufacturing Base Distribution, Product Types
    • 3.4.1 Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Monoclonal Antibodies Product Type
    • 3.4.3 Date of International Manufacturers Enter into Monoclonal Antibodies Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Monoclonal Antibodies Market Size by Type (2015-2020)
    • 4.1.1 Global Monoclonal Antibodies Sales by Type (2015-2020)
    • 4.1.2 Global Monoclonal Antibodies Revenue by Type (2015-2020)
    • 4.1.3 Monoclonal Antibodies Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Monoclonal Antibodies Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Monoclonal Antibodies Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
    • 4.2.3 Monoclonal Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Monoclonal Antibodies Market Size by Application (2015-2020)
    • 5.1.1 Global Monoclonal Antibodies Sales by Application (2015-2020)
    • 5.1.2 Global Monoclonal Antibodies Revenue by Application (2015-2020)
    • 5.1.3 Monoclonal Antibodies Price by Application (2015-2020)
  • 5.2 Monoclonal Antibodies Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Monoclonal Antibodies Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Monoclonal Antibodies Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Monoclonal Antibodies by Country
    • 6.1.1 North America Monoclonal Antibodies Sales by Country
    • 6.1.2 North America Monoclonal Antibodies Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Monoclonal Antibodies Market Facts & Figures by Type
  • 6.3 North America Monoclonal Antibodies Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Monoclonal Antibodies by Country
    • 7.1.1 Europe Monoclonal Antibodies Sales by Country
    • 7.1.2 Europe Monoclonal Antibodies Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Monoclonal Antibodies Market Facts & Figures by Type
  • 7.3 Europe Monoclonal Antibodies Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Monoclonal Antibodies by Region
    • 8.1.1 Asia Pacific Monoclonal Antibodies Sales by Region
    • 8.1.2 Asia Pacific Monoclonal Antibodies Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Type
  • 8.3 Asia Pacific Monoclonal Antibodies Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Monoclonal Antibodies by Country
    • 9.1.1 Latin America Monoclonal Antibodies Sales by Country
    • 9.1.2 Latin America Monoclonal Antibodies Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Monoclonal Antibodies Market Facts & Figures by Type
  • 9.3 Central & South America Monoclonal Antibodies Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Monoclonal Antibodies by Country
    • 10.1.1 Middle East and Africa Monoclonal Antibodies Sales by Country
    • 10.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Type
  • 10.3 Middle East and Africa Monoclonal Antibodies Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Monoclonal Antibodies Products Offered
    • 11.1.5 AbbVie Related Developments
  • 11.2 Roche
    • 11.2.1 Roche Corporation Information
    • 11.2.2 Roche Description and Business Overview
    • 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Roche Monoclonal Antibodies Products Offered
    • 11.2.5 Roche Related Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Corporation Information
    • 11.3.2 Johnson & Johnson Description and Business Overview
    • 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Johnson & Johnson Monoclonal Antibodies Products Offered
    • 11.3.5 Johnson & Johnson Related Developments
  • 11.4 Amgen
    • 11.4.1 Amgen Corporation Information
    • 11.4.2 Amgen Description and Business Overview
    • 11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Amgen Monoclonal Antibodies Products Offered
    • 11.4.5 Amgen Related Developments
  • 11.5 Merck
    • 11.5.1 Merck Corporation Information
    • 11.5.2 Merck Description and Business Overview
    • 11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Merck Monoclonal Antibodies Products Offered
    • 11.5.5 Merck Related Developments
  • 11.6 BMS
    • 11.6.1 BMS Corporation Information
    • 11.6.2 BMS Description and Business Overview
    • 11.6.3 BMS Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 BMS Monoclonal Antibodies Products Offered
    • 11.6.5 BMS Related Developments
  • 11.7 Eli Lilly
    • 11.7.1 Eli Lilly Corporation Information
    • 11.7.2 Eli Lilly Description and Business Overview
    • 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Eli Lilly Monoclonal Antibodies Products Offered
    • 11.7.5 Eli Lilly Related Developments
  • 11.8 Formation Biologics
    • 11.8.1 Formation Biologics Corporation Information
    • 11.8.2 Formation Biologics Description and Business Overview
    • 11.8.3 Formation Biologics Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Formation Biologics Monoclonal Antibodies Products Offered
    • 11.8.5 Formation Biologics Related Developments
  • 11.9 Genmab
    • 11.9.1 Genmab Corporation Information
    • 11.9.2 Genmab Description and Business Overview
    • 11.9.3 Genmab Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Genmab Monoclonal Antibodies Products Offered
    • 11.9.5 Genmab Related Developments
  • 11.10 GlaxoSmithKline
    • 11.10.1 GlaxoSmithKline Corporation Information
    • 11.10.2 GlaxoSmithKline Description and Business Overview
    • 11.10.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 GlaxoSmithKline Monoclonal Antibodies Products Offered
    • 11.10.5 GlaxoSmithKline Related Developments
  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description and Business Overview
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Monoclonal Antibodies Products Offered
    • 11.1.5 AbbVie Related Developments
  • 11.12 mmunogen
    • 11.12.1 mmunogen Corporation Information
    • 11.12.2 mmunogen Description and Business Overview
    • 11.12.3 mmunogen Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 mmunogen Products Offered
    • 11.12.5 mmunogen Related Developments
  • 11.13 MedImmune
    • 11.13.1 MedImmune Corporation Information
    • 11.13.2 MedImmune Description and Business Overview
    • 11.13.3 MedImmune Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 MedImmune Products Offered
    • 11.13.5 MedImmune Related Developments
  • 11.14 Novartis
    • 11.14.1 Novartis Corporation Information
    • 11.14.2 Novartis Description and Business Overview
    • 11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Novartis Products Offered
    • 11.14.5 Novartis Related Developments
  • 11.15 Pfizer
    • 11.15.1 Pfizer Corporation Information
    • 11.15.2 Pfizer Description and Business Overview
    • 11.15.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Pfizer Products Offered
    • 11.15.5 Pfizer Related Developments
  • 11.16 Seattle Genetics
    • 11.16.1 Seattle Genetics Corporation Information
    • 11.16.2 Seattle Genetics Description and Business Overview
    • 11.16.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Seattle Genetics Products Offered
    • 11.16.5 Seattle Genetics Related Developments
  • 11.17 Stemcentrx
    • 11.17.1 Stemcentrx Corporation Information
    • 11.17.2 Stemcentrx Description and Business Overview
    • 11.17.3 Stemcentrx Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Stemcentrx Products Offered
    • 11.17.5 Stemcentrx Related Developments
  • 11.18 Synthon Biopharmaceuticals
    • 11.18.1 Synthon Biopharmaceuticals Corporation Information
    • 11.18.2 Synthon Biopharmaceuticals Description and Business Overview
    • 11.18.3 Synthon Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Synthon Biopharmaceuticals Products Offered
    • 11.18.5 Synthon Biopharmaceuticals Related Developments
  • 11.19 Takeda
    • 11.19.1 Takeda Corporation Information
    • 11.19.2 Takeda Description and Business Overview
    • 11.19.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Takeda Products Offered
    • 11.19.5 Takeda Related Developments
  • 11.20 Teva
    • 11.20.1 Teva Corporation Information
    • 11.20.2 Teva Description and Business Overview
    • 11.20.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Teva Products Offered
    • 11.20.5 Teva Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Monoclonal Antibodies Market Estimates and Projections by Region
    • 12.1.1 Global Monoclonal Antibodies Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Monoclonal Antibodies Revenue Forecast by Regions 2021-2026
  • 12.2 North America Monoclonal Antibodies Market Size Forecast (2021-2026)
    • 12.2.1 North America: Monoclonal Antibodies Sales Forecast (2021-2026)
    • 12.2.2 North America: Monoclonal Antibodies Revenue Forecast (2021-2026)
    • 12.2.3 North America: Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Monoclonal Antibodies Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Monoclonal Antibodies Sales Forecast (2021-2026)
    • 12.3.2 Europe: Monoclonal Antibodies Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Monoclonal Antibodies Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Monoclonal Antibodies Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Monoclonal Antibodies Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Monoclonal Antibodies Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Monoclonal Antibodies Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Monoclonal Antibodies Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Monoclonal Antibodies Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Monoclonal Antibodies Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Monoclonal Antibodies Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Monoclonal Antibodies Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Monoclonal Antibodies Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Monoclonal Antibodies Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Monoclonal Antibodies Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Monoclonal Antibodies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Monoclonal Antibodies market is segmented into
    Cancer
    Autoimmune Diseases
    Infection
    Hematological Diseases
    Others

    Segment by Application, the Monoclonal Antibodies market is segmented into
    Oncology
    Autoimmune and inflammatory diseases
    Respiratory diseases
    Ophthalmology

    Regional and Country-level Analysis
    The Monoclonal Antibodies market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Monoclonal Antibodies market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Monoclonal Antibodies Market Share Analysis
    Monoclonal Antibodies market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Monoclonal Antibodies business, the date to enter into the Monoclonal Antibodies market, Monoclonal Antibodies product introduction, recent developments, etc.

    The major vendors covered:
    AbbVie
    Roche
    Johnson & Johnson
    Amgen
    Merck
    BMS
    Eli Lilly
    Formation Biologics
    Genmab
    GlaxoSmithKline
    Human Genome Sciences
    mmunogen
    MedImmune
    Novartis
    Pfizer
    Seattle Genetics
    Stemcentrx
    Synthon Biopharmaceuticals
    Takeda
    Teva

    Buy now